Links to Guidance and Resources
- A message to GOG Foundation Investigators from Dr. Copeland
- A message to GOG Partners Industry Colleagues from Dr. Copeland
- A Message from the Biopathology Center
- FDA Guidance for Industry, Investigators, and IRBs
- Interim Guidance for Patients on Clinical Trials Supported by CTEP and NCORP
- Additional Guidance Regarding Alternative Procedures for Clinical Trials Supported by CTEP and NCORP
- The Cancer Letter
- Surgical Procedures: SGO/ACOG Position Statement
- COVID-19 Precision Task Force Family Resource Libary (added 3/25)
- Guidance for Collection of Adverse Events Related to COVID-19 Infection (added 3/27)
- SGO COVID-19 Communiqué: Considerations of Continuing Clinical Trials During the COVID-19 Pandemic (added 4/3)
- Virtual SGO Slide Presentation: A Phase 1 Study of XMT 1536 in Patients with Solid Tumors Likely to Express NaPi2b (added 4/3)
- Frequently Asked Questions Regarding COVID-19 And The CIRB (added 4/3)
- COVID-19 and Cancer (added 6/22)
- Clinical Trials, Adaptability and the COVID-19 Pandemic (added 12/17)